Combining array‐based approaches for the identification of candidate tumor suppressor loci in mature lymphoid neoplasms
Open Access
- 1 October 2007
- Vol. 115 (10) , 1107-1134
- https://doi.org/10.1111/j.1600-0463.2007.apm_883.xml.x
Abstract
Tumor suppressor gene (TSG) inactivation by chromosomal deletions and/or mutations is a well-characterized genetic alteration in lymphomas. Array-based technologies have greatly increased the detection and characterization of chromosomal imbalances and regions with loss of heterozygosity (LOH), leading to the identification of a number of novel candidate TSG loci. In addition, microarray platforms for studying DNA methylation and histone modifications enable identifying epigenetic changes affecting gene expression of TSG. Combining these microarray technologies with gene expression profiling is a promising strategy to discover novel TSG in regions targeted by genetic or epigenetic alterations. In this review we present an outline of methodological aspects of the various microarray technologies, and discuss their potentials and restrictions. Furthermore, we survey research findings derived from these high-throughput techniques, which are allowing a deeper insight into the mechanisms of lymphomagenesis.Keywords
This publication has 148 references indexed in Scilit:
- DNA methylation profiling of human chromosomes 6, 20 and 22Nature Genetics, 2006
- Application of array CGH on archival formalin-fixed paraffin-embedded tissues including small numbers of microdissected cellsLaboratory Investigation, 2006
- Control of Developmental Regulators by Polycomb in Human Embryonic Stem CellsCell, 2006
- Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cellsNature Genetics, 2005
- Fine-scale structural variation of the human genomeNature Genetics, 2005
- Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancerNature Genetics, 2004
- A strategy for disease gene identification through nonsense-mediated mRNA decay inhibitionNature Biotechnology, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993